Search News
| 343.28 Delayed Data As of 4:00pm ET |  -0.83 / -0.24%Today’s Change | 249.17 Today|||52-Week Range 388.67 | +7.76% Year-to-Date |
| Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar? 7:23am / Zacks.com - Paid Partner Content | Vertex's Cystic Fibrosis Drug Gets FDA Nod for Children Aug 16 / Zacks.com - Paid Partner Content |
| Lilly (LLY) Hits 52-Week High, Can the Run Continue? Aug 17 / Zacks.com - Paid Partner Content | Pax World Management Llc Buys Eli Lilly and Co, International Business Machines Corp,... Aug 16 / GuruFocus News - Paid Partner Content |
| Is Biogen (BIIB) Outperforming Other Medical Stocks This Year? Aug 17 / Zacks.com - Paid Partner Content | Biotech ETFs in Focus on String of Q2 Earnings Beat Aug 10 / Zacks.com - Paid Partner Content |
| Has Biogen (BIIB) Outpaced Other Medical Stocks This Year? Aug 17 / Zacks.com - Paid Partner Content | PDL BioPharma (PDLI) Q2 Earnings Top, Revenues Slump Y/Y Aug 09 / Zacks.com - Paid Partner Content |
| Pain Therapeutics' Shares Rally on Alzheimer's Study Grant Aug 16 / Zacks.com - Paid Partner Content |
| Previous close | 344.11 |
| Today’s open | 345.70 |
| Day’s range | 343.00 - 346.39 |
| Volume | 625,286 |
| Average volume (3 months) | 1,806,739 |
| Market cap | $68.6B |
| Earnings growth (last year) | -29.56% |
| Earnings growth (this year) | +16.16% |
| Earnings growth (next 5 years) | +7.20% |
| Revenue growth (last year) | +7.81% |
| P/E ratio | 24.3 |
| Price/Sales | 6.17 |
| Price/Book | 5.71 |
| Next reporting date | October 24, 2018 |
| EPS forecast (this quarter) | $6.80 |
| Annual revenue (last year) | $11.0B |
| Annual profit (last year) | $2.5B |
| Net profit margin | 23.10% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michel Vounatsos |
Chief Financial Officer & Executive Vice President Jeffrey D. Capello |
Corporate headquarters Cambridge, Massachusetts |
